What is Erica Tillman's NPI number?

Erica Tillman's National Provider Identifier (NPI) is 1841585890, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Erica Tillman's specialty?

Erica Tillman is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Erica Tillman located?

Erica Tillman's practice location on file with NPPES is 2401 S 31st St, Temple, TX 76508-0001.

What is Erica Tillman's phone number?

The practice phone number listed in the NPPES registry for Erica Tillman is (254) 724-2111.

Does Erica Tillman accept Medicare?

Erica Tillman is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Erica Tillman's NPI active?

Yes — Erica Tillman's NPI (1841585890) is active in the NPPES registry as of the last update on 2023-08-02.

IndividualActiveAccepts Medicare

Erica Tillman, M.D.

NPI 1841585890 · Dermatology Physician · Temple, TX

Erica Tillman, M.D. is a Dermatology Physician provider in Temple, TX (NPI 1841585890).

Provider details

NPI number: 1841585890
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: M.D.
Sex: Female
Sole proprietor: No
License: BP10041339 (TX)

Practice location

2401 S 31st St

Temple, TX 76508-0001

Phone: (254) 724-2111

Street-level locationGet directions

More TX providers

Mailing address

Po Box 844658

Dallas, TX 75284-4658

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense Q3981 (TX)
Allopathic & Osteopathic Physicians
Internal Medicine Physician207R00000XLicense BP10041339 (TX)
Allopathic & Osteopathic Physicians

Additional practice locations (1)

23050 Westheimer Pkwy
Katy, TX 77494-3596
Phone: (281) 394-9500
Fax: (281) 394-5350

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(71/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
15 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
2 documented practice locations
Medicare service volume (vs. specialty peers)25% of score
1,436 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	570	$2
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	211	$93
Destruction of Precancer Skin Growth, 1 Growth17000	141	$48
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	128	$62
Biopsy of Related Skin Growth, First Growth11102	86	$24
Destruction of Skin Growth, 1-14 Growths

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 16 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Clobetasol Propionate	116	62
Ketoconazole	71	36
Mupirocin	48	32
Triamcinolone Acetonide	43	26
Clindamycin Phosphate	43	16
Fluorouracil	36	29
Spironolactone	36	—
Doxycycline Monohydrate	21

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$26 across 1 record (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2011-06-16
Last updated: 2023-08-02
Certified: 2023-08-02

Frequently asked questions

What is Erica Tillman's NPI number?: Erica Tillman's National Provider Identifier (NPI) is 1841585890, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Erica Tillman's specialty?: Erica Tillman is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Erica Tillman located?: Erica Tillman's practice location on file with NPPES is 2401 S 31st St, Temple, TX 76508-0001.
What is Erica Tillman's phone number?: The practice phone number listed in the NPPES registry for Erica Tillman is (254) 724-2111.
Does Erica Tillman accept Medicare?: Erica Tillman is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Erica Tillman's NPI active?: Yes — Erica Tillman's NPI (1841585890) is active in the NPPES registry as of the last update on 2023-08-02.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	570	$2
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	211	$93
Destruction of Precancer Skin Growth, 1 Growth17000	141	$48
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	128	$62
Biopsy of Related Skin Growth, First Growth11102	86	$24
Destruction of Skin Growth, 1-14 Growths

Drug

Part D claims (2024)

Beneficiaries

Clobetasol Propionate

116

Ketoconazole

Mupirocin

Triamcinolone Acetonide

Clindamycin Phosphate

Fluorouracil

Spironolactone

—

Doxycycline Monohydrate

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$26 across 1 record (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Additional practice locations (1)

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Additional practice locations (1)

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments